Improve the quality of life for cystic fibrosis (CF) patients by timely detection of CFTR gene variants.

Cystic Fibrosis (CF) is the most prevalent life-limiting autosomal recessive disorder in the Caucasian population. ViennaLab offers population-tailored CF StripAssays® including 46 common Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutations and the polyT variant 5T/7T/9T in intron 8.

 

Cystic Fibrosis (CF)

 

  • CF patients typically show decreased pulmonary function accompanied by persistent respiratory infections, pancreatic insufficiency, malnutrition and male infertility.
  • The disease prevalence is estimated to be 1 in 2,500 to 4,000 live births.
  • Clinical manifestations vary in severity depending on the underlying CFTR mutations, ranging from classical CF to the milder forms of CFTR-related disorders.
  • Therapies to improve the quality of life of CF patients are available and aim for the prevention of complications and controlling the symptoms.
  • In newborn screening, CFTR genotyping enables early diagnosis and minimizes emotional stress for parents.

 

ProductREFUnit SizeIFUBrochure
CF StripAssay®4-41010 tests

PDF

PDF

CF StripAssay® TUR4-42010 tests

PDF

PDF

CF StripAssay® GER4-43010 tests

PDF

PDF